Nimrah Najeeb
Overview
Nimrah Najeeb is a counsel in Crowell & Moring’s Washington, D.C. office and a member of the firm’s International Trade group. Nimrah focuses her practice on cross-border transactions and national security matters, including reviews conducted by the Committee on Foreign Investment in the United States (CFIUS), as well as economic sanctions, export controls, and anti-money laundering. Nimrah represents clients in all stages of the CFIUS process, including conducting diligence and national security risk assessments, evaluating CFIUS jurisdictional issues, advising on deal structure and strategy, preparing CFIUS filings, and negotiating complex mitigation agreements.
Career & Education
- Bryn Mawr College, B.A., cum laude, political science and history, 2010
- Fordham University School of Law, J.D., 2013
- District of Columbia
- New York
- Urdu
Nimrah's Insights
Firm News | 2 min read | 05.22.26
May 22, 2026: A Crowell & Moring team represented Kanders & Company in a complex carveout transaction in which Kanders acquired the biosecurity business of publicly traded Ginkgo Bioworks. The resulting company, Perimeter Systems, has launched as the world’s first integrated biosecurity infrastructure platform, designed to transform biological signals into real-time intelligence and accelerate decisive response. At closing, Perimeter secured $60 million in growth capital, led by Kanders in partnership with SCS Financial, Goldcrest Capital, Four Cities Capital, and the Safe Artificial Intelligence Fund (SAIF).
Client Alert | 2 min read | 02.12.26
Firm News | 1 min read | 07.01.25
Crowell Represents Parsons Corporation in Strategic $89M Acquisition
Insights
- |
02.12.26
Crowell & Moring’s International Trade Law
Nimrah's Insights
Firm News | 2 min read | 05.22.26
May 22, 2026: A Crowell & Moring team represented Kanders & Company in a complex carveout transaction in which Kanders acquired the biosecurity business of publicly traded Ginkgo Bioworks. The resulting company, Perimeter Systems, has launched as the world’s first integrated biosecurity infrastructure platform, designed to transform biological signals into real-time intelligence and accelerate decisive response. At closing, Perimeter secured $60 million in growth capital, led by Kanders in partnership with SCS Financial, Goldcrest Capital, Four Cities Capital, and the Safe Artificial Intelligence Fund (SAIF).
Client Alert | 2 min read | 02.12.26
Firm News | 1 min read | 07.01.25
Crowell Represents Parsons Corporation in Strategic $89M Acquisition




